News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
Presentation DES vs DCB Revascularization in Patients With Femoropopliteal Arterial Disease February 11, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
Presentation 12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment May 08, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2018 Shelley Wood March 01, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
Presentation CCVVC 2016 Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials Presenter: Tyrone Collins June 15, 2016
Presentation CCVVC 2016 The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions Presenter: Chris Metzger June 15, 2016
News Conference News ISET 2016 Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions Michael O'Riordan February 15, 2016
News Industry News Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter November 30, 2015
News Daily News PAD Patients Do Better When Endovascular Therapy Added to Exercise Program Caitlin E. Cox November 15, 2015
News Daily News A los Pacientes EAP les Va mejor cuando el Tratamiento Endovascular se Suma a un Programa de Ejercicio Físico Caitlin E. Cox November 15, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015